282 related articles for article (PubMed ID: 18672973)
21. Palliative ultrasound-guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs.
Cerf DJ; Lindquist EC
J Am Vet Med Assoc; 2012 Jan; 240(1):51-60. PubMed ID: 22171755
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
24. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
25. Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis.
Green M; Filippou A; Sant G; Theoharides TC
Urology; 2004 Apr; 63(4):688-93. PubMed ID: 15072882
[TBL] [Abstract][Full Text] [Related]
26. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53.
Landolfi JA; Terio KA
Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444
[TBL] [Abstract][Full Text] [Related]
27. Canine prostate carcinomas express markers of urothelial and prostatic differentiation.
LeRoy BE; Nadella MV; Toribio RE; Leav I; Rosol TJ
Vet Pathol; 2004 Mar; 41(2):131-40. PubMed ID: 15017026
[TBL] [Abstract][Full Text] [Related]
28. Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas.
Bongiovanni L; Colombi I; Fortunato C; Della Salda L
Vet Dermatol; 2009 Oct; 20(5-6):369-76. PubMed ID: 20178473
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
[TBL] [Abstract][Full Text] [Related]
31. Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line.
Kaewsakhorn T; Kisseberth WC; Capen CC; Hayes KA; Calverley MJ; Inpanbutr N
Anticancer Res; 2005; 25(4):2689-96. PubMed ID: 16080513
[TBL] [Abstract][Full Text] [Related]
32. [Transitional cell carcinoma of the urinary bladder of a dog].
Odendaal JS; Bastianello SS
J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501
[TBL] [Abstract][Full Text] [Related]
33. Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder.
Matsuyama M; Funao K; Hayama T; Tanaka T; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Urology; 2009 Apr; 73(4):916-21. PubMed ID: 19167045
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factors and their specific binding sites in normal urothelium and transitional cell carcinoma (TCC) of the human bladder.
Palcy S; Chopin DK; Caruelle D; Ravery V; Barritault D; Caruelle JP
Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):565-75. PubMed ID: 7549793
[TBL] [Abstract][Full Text] [Related]
35. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
Wilson HM; Chun R; Larson VS; Kurzman ID; Vail DM
J Am Vet Med Assoc; 2007 Jul; 231(1):101-6. PubMed ID: 17605672
[TBL] [Abstract][Full Text] [Related]
36. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
[TBL] [Abstract][Full Text] [Related]
37. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
Hou JQ; He J; Wen DG; Chen ZX; Zeng J
Chin Med J (Engl); 2006 Jul; 119(13):1118-20. PubMed ID: 16834932
[No Abstract] [Full Text] [Related]
38. Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder.
Naughton JF; Widmer WR; Constable PD; Knapp DW
Am J Vet Res; 2012 Dec; 73(12):1919-24. PubMed ID: 23176418
[TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
40. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].
Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
